These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3403105)

  • 1. Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin.
    Acerbi D; Bonati C; Boscarino G; Bufalino L; Cesari F; D'Ambrosio E; Mansanti P; Scali G
    Int J Clin Pharmacol Res; 1988; 8(3):175-80. PubMed ID: 3403105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
    Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
    Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
    Warrington S; Debbas N; Farthing M; Horton M; Umile A
    Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of age on piroxicam disposition in rheumatoid arthritis.
    Blocka KL; Richardson CJ; Wallace SM; Ross SG; Verbeeck RK
    J Rheumatol; 1988; 15(5):757-63. PubMed ID: 3172091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain.
    Dolci G; Ripari M; Pacifici L; Umile A
    Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
    Lister RE; Acerbi D; Cadel S
    Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.
    Deroubaix X; Stockis A; Allemon AM; Lebacq E; Acerbi D; Ventura P
    Eur J Clin Pharmacol; 1995; 47(6):531-6. PubMed ID: 7768257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
    Wang D; Miller R; Zheng J; Hu C
    J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    Reginster JY; Franchimont P
    Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the antalgic activity and tolerability of piroxicam in chronic pain in cervicoarthrosis and lumboarthrosis].
    Minisola G; Dardano B
    Clin Ter; 1989 Oct; 131(2):73-82. PubMed ID: 2533023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam.
    Cadel S; Bongrani S
    Acta Physiol Hung; 1990; 75 Suppl():45-6. PubMed ID: 2371898
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR
    Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
    Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.
    Redenti E; Zanol M; Ventura P; Fronza G; Comotti A; Taddei P; Bertoluzza A
    Biospectroscopy; 1999; 5(4):243-51. PubMed ID: 10478955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph.
    Kimura E; Bersani-Amado CA; Sudo LS; Santos SR; Oga S
    Gen Pharmacol; 1997 May; 28(5):695-8. PubMed ID: 9184804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.
    Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
    Pharmacotherapy; 1998; 18(2):295-301. PubMed ID: 9545149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of nicotine in healthy elderly people.
    Molander L; Hansson A; Lunell E
    Clin Pharmacol Ther; 2001 Jan; 69(1):57-65. PubMed ID: 11180039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of sertindole in healthy young and elderly male and female subjects.
    Wong SL; Cao G; Mack RJ; Granneman GR
    Clin Pharmacol Ther; 1997 Aug; 62(2):157-64. PubMed ID: 9284851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pH dependent molecular conformation and dimerization phenomena of piroxicam on the drug:cyclodextrin complex stoichiometry and its chromatographic behaviour. A new specific HPLC method for piroxicam:cyclodextrin formulations.
    Rozou S; Voulgari A; Antoniadou-Vyza E
    Eur J Pharm Sci; 2004 Apr; 21(5):661-9. PubMed ID: 15066667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.